Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If we were R/S now at .009 after Split we be at $9 pps if we can get that to $90 pps we might be ok
They may want to get on NASDAQ right away is my thinking.
Wow huge news. I saw they started trials Oct 2019. With PR this will fly.
Alright nice thanks for updated DD. PR on adva27 will be huge. Plus we're entering billion dollar market for Covid
I agree especially after huge yesterday. Very strong today considering yesterdays move. Trending higher
Adva27 cancer drug showing huge promise. 3x better than current treatment and used for drug resistant breast cancer. Worldwide patent until 2033. Don't get against this or you will fail.
We had a 500% day yesterday and we will finish green today and minor retrace
CCI on chart showing we VERY close folks, 009 Break today will be glorious.
If there's any update coming for their anti-cancer drug then we do see dollars. Especially with this tiny o/s.
Latest PR on their anti-cancer drug
October 17, 2019
SUNSHINE BIOPHARMA INITIATES Adva-27a XENOGRAFT STUDIES IN MICE CARRYING
DIFFERENT TYPES OF HUMAN CANCER
Montreal, Quebec, Canada – (ACCESSWIRE) – Sunshine Biopharma, Inc. (OTC Markets:
“SBFM”), a pharmaceutical company focused on the research, development and
commercialization of drugs for the treatment of aggressive forms of cancer, today announced
that it has initiated studies of Adva-27a in xenograft mice. In these studies, specifically
engineered mice which have developed tumors following injection with patient derived cancer
cells are treated with Adva-27a to assess the ability of the drug to shrink the tumors. Among the
different types of patient derived cancer types being studied are Pancreatic Cancer, Breast
Cancer, Small-Cell Lung Cancer and Uterine Sarcoma.
About Adva-27a
Adva-27a is Sunshine Biopharma’s proprietary anticancer compound. In vitro tests conducted
on Adva-27a have demonstrated the drug’s effectiveness at destroying Multidrug Resistant
Cancer Cells including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer
cells, and Uterine Sarcoma cells. Clinical trials for Pancreatic Cancer indication are planned to
be conducted at McGill University’s Jewish General Hospital in Montreal, Canada.
We have adva27 cancer drug - anyone know when the next update will be on that?
Our licensor, Advanomics Corporation, has developed a way to replace the diester bond with a Carbon-Difluoride bond which acts as a perfect diester isostere. This technology allows us to create a large variety of therapeutic compounds that are completely stable and often more active than the original drugs. This unique capability allowed us to create our Lead Compound, Adva-27a, an effective and highly specific Topoisomerase II (Top2) Inhibitor.
According to Sunshine, Adva-27a has been shown to be effective at killing cells of several cancers—including pancreatic cancer, multidrug resistant breast cancer, small-cell lung cancer, and uterine sarcoma.
Chart is now trending up in a big way. This small downturn was good for the RSI. Now we have clean ride up .03+ this week.
Nice huge run now shorts can cover all day
Cover up to .05
Looks like weak hands are out - now we can move up to .025 - 03 range.
Go Green - Massive covid 19 patent news - already a good company small o/s. Undervalued easy .05 from here
Volume is still here I think we see continuation - HUGE Green day.
Nice close, could be .05 runner and still be undervalued.
Wow nice massive big buyers bring it right back up. I'm impressed by the strength of the trading action.
If there's a war in India vs China, or USA vs Venezualea we goto $5. Mark it.
#1 Breakout Board, #7 Most Read Board
PASO = Nasdaq in July ? Hold for gold imo! We have 45 days for this to hit $4.00 if I'm correct.
3. CLX shall acquire, subject to the completion of due diligence, the execution of a Definitive Agreement and
Board and Shareholder (if necessary) approval, 10 million shares of preferred Series Stock of PASO. It is
understood by the parties with joint financial interest in CLX acquiring control of PASO is to effectuate a
reverse merger between PASO and CLX Healthcare Joint Venture partnership “CLX” (“Acquisition”).
4. The Closing shall be on July 15, 2020 or sooner, unless the parties hereto agree to another time.
Technically it's better than just UST Global acquiring PASO. It's both SiruisQ and UST Global acquiring PASO. Am I wrong?
UST Global will be appointing execs into PASO board of directors. You can call it a joint venture all you want. But I know what I own.
Excellent someone plan a party in the Florida keys
I smell a penny runner next week, MARK IT
3yr High is 0.44
Look for us to blow through that in coming days.
Tick Tock until BOOM goes the Dynamite!
Why you folks playing dead tickers last updated in 2007 ?
Red to green inbound, buckle up!
I'm back in this Heavy guys! I see reversal, RSI reset, ready for lift off!
True +142% is a huge amount of selling LOL
I smell a penny runner
On the plus side we've reset the RSI from 97 to 50's... now we can run through .25 with little to no resistance
Set your sells above $2 and buckle up
That's like 1 billion of rocket fuel when we have news like this and solid no-debt runner.
Yep company that does 1.8Billion annual revenues. I guess they just decided to take em over for 100m or something, could see $2 near term if thats the case 55m O/S
True unicorn here, not ihub something much bigger is afoot imo